Shares in Pacific Biosciences (PacBio) dropped 51% after the company reduced its annual operating expense run rate by $50-$75 million, equivalent to 86%-128% of its expected 2023 revenue of $58.4 million. CEO Christian Henry blamed a decrease in customer spending and said the firm was reducing its full-year revenue expectations to $170-200 million, compared with an earlier figure of $200.5 million.
UK councils are paying out a fortune in data breach claims
Several UK councils have paid compensation for data breaches in the past year, resulting in significant financial costs. Notable incidents have led to thousands of
